
Company valuation, historical trends, and peer comparisons.
According to Ipsen S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.85B. This represents a change of 21.49% compared to the average of 9.75B of the last 4 quarters.
The mean historical Enterprise Value of Ipsen S.A. over the last ten years is 7.96B. The current 11.85B Enterprise Value has changed 48.88% with respect to the historical average. Over the past ten years (40 quarters), IPSEF's Enterprise Value was at its highest in in the June 2026 quarter at 12.95B. The Enterprise Value was at its lowest in in the June 2012 quarter at 1.55B.
Average
7.96B
Median
8.36B
Minimum
5.59B
Maximum
9.64B
Discovering the peaks and valleys of Ipsen S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.99%
Maximum Annual Enterprise Value = 9.64B
Minimum Annual Increase = -20.30%
Minimum Annual Enterprise Value = 5.59B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 9.28B | 4.19% |
| 2024 | 8.91B | 0.57% |
| 2023 | 8.86B | 11.42% |
| 2022 | 7.95B | 19.00% |
| 2021 | 6.68B | 7.97% |
| 2020 | 6.19B | -19.42% |
| 2019 | 7.68B | -20.30% |
| 2018 | 9.64B | 9.80% |
| 2017 | 8.78B | 56.99% |
| 2016 | 5.59B | 15.09% |
The current Enterprise Value of Ipsen S.A. (IPSEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
9.02B
5-year avg
8.34B
10-year avg
7.96B
Ipsen S.A.’s Enterprise Value is greater than Innate Pharma S.A. (128.31M), greater than OSE Immunotherapeutics S.A. (61.33M), greater than Abivax S.A. (6.27B), greater than Transgene S.A. (206.07M), greater than Valerio Therapeutics S.A. (223.45M), greater than TME Pharma N.V. (12.72M), greater than Cellectis S.A. (128.27M), greater than Nanobiotix S.A. (1.29B), greater than MaaT Pharma S.A. (26.06M), greater than THX Pharma (50.17M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 128.31M | $114.56M | |
| 61.33M | $43.51M | |
| 6.27B | $6.66B | |
| 206.07M | $208.14M | |
| 223.45M | $211.27M | |
| 12.72M | $10.86M | |
| 128.27M | $70.88M | |
| 1.29B | $1.29B | |
| 26.06M | $19.39M | |
| 50.17M | $48.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ipsen S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ipsen S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ipsen S.A.'s Enterprise Value?
What is the highest Enterprise Value for Ipsen S.A. (IPSEF)?
What is the 3-year average Enterprise Value for Ipsen S.A. (IPSEF)?
What is the 5-year average Enterprise Value for Ipsen S.A. (IPSEF)?
How does the current Enterprise Value for Ipsen S.A. (IPSEF) compare to its historical average?